genetic

(redirected from Genetic heterogeneity)
Also found in: Dictionary, Thesaurus, Medical.
Related to Genetic heterogeneity: Incomplete penetrance

genetic

adjective atavistic, congenital, hereditary, ingrained, inherited, innate
See also: born, hereditary, innate, native
References in periodicals archive ?
The present study is a first attempt to understand the genetic heterogeneity and gene diversity in the Southern Punjab populations by utilizing ABO and Rh loci.
4) Therefore, an expert panel was convened to define HER2 genetic heterogeneity in breast tumors to reduce subjectivity in HER2 interpretation by the pathologist for fluorescence in situ hybridization testing.
Unusual splice-site mutations in the RSK2 gene and suggestion of genetic heterogeneity in Coffin-Lowry syndrome.
If HER2 GH is present, there should also be a statement in the interpretation: "HER2 Genetic Heterogeneity is present.
Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum.
The genetic heterogeneity between this variant and other strains in the East/Central Africa lineage has a magnitude equivalent to or higher than that observed between strains of West Nile virus circulating in southern Europe and the Middle East for the past 4 decades and which emerged and dispersed in the United States in 1999.
Beyond these cancer-initiating engineered mutations, the resultant tumors acquire common and distinct spontaneous mutations during tumor progression, providing additional natural genetic variation more akin to the range of genetic heterogeneity encountered across different primary human tumors.
Currently, TTV and TTMV are classified as distinct species in the floating (although closely linked to the family Circoviridae) genus Anellovirus, but their extreme genetic heterogeneity and some distinctive features in genomic organization have led some to suggest that they should be classified as an independent family (2,3).
Genetic heterogeneity of mannose-binding proteins: the Jekyll and Hyde of innate immunity.
High prevalence of human metapneumovirus infection in young children and genetic heterogeneity of the viral isolates.
Mutation mapping is fundamental for "cascade" screenings of CF families (6), because screening programs on general populations are limited by the genetic heterogeneity of the disease.
Perlegen's comprehensive understanding of the genetic heterogeneity of human disease as well as our pharmacogenomics approach, searching for genetic markers that can be used to predict patient response, may address this enormous challenge.